KFF November 10, 2022
Juliette Cubanski, Anthony Damico

During the Medicare open enrollment period from October 15 to December 7 each year, beneficiaries can enroll in a plan that provides Part D prescription drug coverage, either a stand-alone prescription drug plan (PDP) for people in traditional Medicare, or a Medicare Advantage plan that covers all Medicare benefits, including prescription drugs (MA-PD). In 2022, 49 million of the 65 million people covered by Medicare are enrolled in Part D plans, with more than half (53%) enrolled in MA-PDs and 47% in PDPs. This issue brief provides an overview of the Medicare Part D marketplace in 2023 and key trends over time, focusing primarily on PDPs. (A separate overview of the 2023 Medicare Advantage market is also available.) The brief...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Insurance, Medicare, Medicare Advantage, Patient / Consumer
Medicare’s Selection Of 15 More Drugs For Price Negotiation Puts Spotlight Back On IRA
How Many Physicians Have Opted Out of the Medicare Program? - 2
MedPAC Members Vote to Recommend Pay Hikes for Physicians and Hospitals
Opinion: Former Trump health official: Medicare should cover Wegovy — but not negotiate its price
Medicare will negotiate Novo’s GLP-1 drug price. Here’s what that means for Ozempic, Wegovy.

Share This Article